Study identifier:SD-005-0705
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A double-blind, double-dummy, randomized, placebo-controlled, cross-over exploratory study to assess the efficacy of Rhinocort Aqua (budesonide) nasal spray in combination with intranasal Oxis Turbuhaler in an allergic Rhinitis challenge model - Test of Concept
Allergic Rhinitis
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|